⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

January 1, 2012BioMed Research InternationalOpen Access

Physiologically Based Pharmacokinetic Modeling in Pediatric Drug Development: A Clinician’s Request for a More Integrated Approach

View Full Paper

Ask AI

Bookmark

Share

Abstract

sponsorship: NICHD NIH HHS|R01 HD060543, NICHD NIH HHS|R01 HD048689, NICHD NIH HHS|U54HD071601, NICHD NIH HHS|R01HD060543, NICHD NIH HHS|U54 HD071601, NICHD NIH HHS|R01HD048689, NIDA NIH HHS|K24DA027992, NIDA NIH HHS|K24 DA027992

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Allegaert et al. (2012) studied this question.

synapsesocial.com/papers/6a896ef63e20d39e4b3e7c19 https://doi.org/10.1155/2012/103763

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Resurgence in the use of physiologically based pharmacokinetic models in pediatric clinical pharmacology: parallel shift in incorporating the knowledge of biological elements and increased applicability to drug development and clinical practiceOriginal Research · 2010 · 169 citations
2The role of population PK–PD modelling in paediatric clinical researchHuman Clinical Trial · 2010 · 214 citations
3Renal Drug Clearance in Preterm Neonates: Relation to Prenatal GrowthOriginal Research · 2007 · 105 citations
4The In Silico Child: Using Simulation to Guide Pediatric Drug Development and Manage Pediatric PharmacotherapyOriginal Research · 2009 · 70 citations
5Physiologically Based Pharmacokinetic Modeling: Methodology, Applications, and Limitations with a Focus on Its Role in Pediatric Drug DevelopmentRisk Assessment · 2011 · 153 citations